Comparison of serologic and protective responses induced by two Pasteurella vaccines.
Vaccine development for the prevention of pneumonic pasteurellosis remains a critical issue for the feedlot industry. Most currently available Pasteurella vaccines are formulated to stimulate immunity by either providing an adequate antigenic mass in the administered dose, or by relying on subsequent production of antigens by in vivo growth of live organisms. The ability of these different types of vaccines to stimulate rapid and high titres to key antigens is a key factor that will influence subsequent resistance to disease. The serologic and protective responses to a streptomycin-dependent, modified-live vaccine and a killed (bacterin-toxoid) vaccine against experimental pneumonic pasteurellosis were compared. Calves were vaccinated with a single injection of either a test vaccine or phosphate-buffered saline, challenged 14 d later by transthoracic injection with Pasteurella haemolytica, and euthanized 3 d post-challenge to evaluate the severity of pneumonia. On days 0, 7, and 14, serologic responses to various P. haemolytica antigens, including cell-associated and soluble antigens, were determined by enzyme-linked immunosorbent assays, and anti-leukotoxin antibody levels were determined by leukotoxin neutralization. The bacterin-toxoid elicited significantly greater serologic responses compared to controls for all antigens. The modified-live vaccine elicited a significantly greater response compared to controls for a whole-cell antigen preparation. Lesion scores were significantly smaller (greater protection) in calves that received the bacterin-toxoid, but not the modified-live vaccine, compared to controls.
Mosier
D A
DA
Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manahattan 66506, USA.
Panciera
R J
RJ
Rogers
D P
DP
Uhlich
G A
GA
Butine
M D
MD
Confer
A W
AW
Basaraba
R J
RJ
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D001427:Bacterial Toxins / Q000276:immunology; D001428:Bacterial Vaccines; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology* / Q000503:physiopathology / Q000517:prevention & control; D004797:Enzyme-Linked Immunosorbent Assay; D005098:Exotoxins / Q000276:immunology; D016978:Mannheimia haemolytica / Q000276:immunology*; D009500:Neutralization Tests; D012766:Pasteurellosis, Pneumonic / Q000276:immunology* / Q000503:physiopathology / Q000517:prevention & control; D013997:Time Factors; D015164:Vaccines, Inactivated
D000907:Antibodies, Bacterial; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D005098:Exotoxins; D015164:Vaccines, Inactivated; C018579:leukotoxin